Iota-carrageenan nasal spray has been shown to reduce the titres of respiratory viruses and to reduce the severity of symptoms in placebo-controlled clinical trials, including children and adults. The results of four clinical trials are presented. Conclusion: Iota-carrageenan is a good candidate as...
It is currently undergoing a Phase 2 clinical trials as a nasal spray for the potential prevention and treatment of viral pneumonia caused by SARS-CoV-2 or other respiratory viruses [299], or for treatment of patients hospitalised with SARS-CoV-2 as an inhaled formulation [300]. It appears ...
Nasal airflow asymmetry and the effects of a topical nasal decongestant. Rhinology. 1992;30(4):277–282. 4. Castellano F, Mautone G. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect...
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial 107. Respir Res. 2013;14:124. 13. Morokutti-Kurz M, Konig-Schuster M, Koller C, et al. The intranasal application of zanamivir and carrageenan is synergistically active against influenza A virus ...
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med. 2012;12:147.Fazekas T, Eickhoff P, Pruckner N, Vollnhofer G, Fischmeister G, Diakos C, ...
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial 107. Respir Res. 2013;14:124. 13. Morokutti-Kurz M, Konig-Schuster M, Koller C, et al. The intranasal application of zanamivir and carrageenan is synergistically active against influenza A virus ...
A recent study reported the evaluation of a nasal spray containing xylometazoline HCl and iota-CG. In vitro experiments revealed that the combination of the vasoconstrictive properties of the drug and the antiviral activity of iota-CG were effective against human rhinovirus (hRV) 1a, hRV8, and...